Drug Safety Solutions

Pharmacovigilance Services - The continuous monitoring of the use of products to promptly identify potential safety issues and help protect public health.

Epidemiology and Risk Management Services - The experience and expertise to help you meet a product’s safety information needs.

Signal Detection & Evaluation - i3 Aperio™ allows for the identification of real-time signals that could indicate a drug’s potential safety issues.

i3 Drug Safety provides the data and services to help you meet regulatory requirements and support risk management programs for:

  • Drugs
  • Devices
  • Biologics
  • Vaccines

...throughout the product development and commercialization lifecycle.

Our services

  • Integrated global pharmacovigilance services in both pre- and post-marketing settings
  • Development and implementation of risk management and risk minimization plans
  • Epidemiology, specializing in advanced pharmacoepidemiologic studies for marketed products and supporting a full spectrum of epidemiology services that include observational study design and analysis, and pharmacogenetics studies

Proven research and methodology leadership

i3 Drug Safety is staffed by leaders in epidemiologic design and practice who have spoken at the FDA, EMEA, and scores of professional congresses and published in top medical and drug safety journals. Our experience, which includes key product studies, places us at the forefront of research and methodology, enabling us to provide you with the best in:

  • Reliability
  • Clarity
  • Data quality
  • Technical expertise

We apply scientific rigor, innovative methods,
and proven expertise to help establish a safer
health care experience for all.

Why i3 Drug Safety?

Our broad capabilities and deep expertise in all areas of drug safety, combined with unique resources and innovative products, enable us to provide accurate and timely services that help you manage risk and change effectively.